$212.70 0.00 (0.00%)
19:38 EST AET Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 69.57B
PE Ratio 20.33
Volume (Avg. Vol.)
Day's Range 212.70 - 212.70
52-Week Range -
Dividend & Yield 2.00 (0.94%)
AET Stock Predictions, Articles, and Aetna News
- From InvestorPlace
- From the Web
CVS is going to acquire Aetna, and Aetna stock is priced accordingly, meaning now looks like a good time to take profits.
Aetna stock has soared of late as its merger with CVS appears likely to be approved. AET stock is tapped out, but CVS looks like a buy.
Lowe's (LOW) is planning to close down all of its Orchard Supply Hardware stores in the U.S. to better focus on its core business.
The surprise judgment on Tuesday in favor of the AT&T (T)/Time Warner (TWX) merger is probably going to give media stocks a small boost in the short term, but another stock that could benefit from the shift in favor of larger mergers is AmerisourceBergen Corporation (ABC).
These are the stocks that helped hedge funds bounce back in early 2018 and out-perform the market by a considerable margin.
There's no particular reason to buy AET stock now, but CVS shareholders have good reason to be excited about the Aetna merger.
AET stock is priced as if it doesn't have a sizable M&A catalyst on the table, but it does, and that makes the stock an attractive option at current levels.
Walmart (WMT) is reportedly in talks to acquire health insurer Humana (HUM), but the finer details of the discussions are still unknown.
Larry Robbins is a well-known GARP investor. Here are some of his hedge fund's -- Glenview Capital Management -- most undervalued stocks.
CVS's acquisition of Aetna is all but a sure thing, and AET stock is set to surge as a result. Here's what investors need to know.
The reports of Walgreens Boots Alliance buying out AmerisourceBergen failed to move WBA stock...with good reason.
AmerisourceBergen (ABC) stock was on the rise Tuesday on news of a possible takeover approach by Walgreens Boots Alliance (WBA).
While Aetna's numbers aren't great, the merger of CVS and AET should be a good long-term play. There is long-term synergy in combining pharmacy and health benefits with preventative care.
Stocks suffered a rare bout of weakness on Tuesday - the worst loss since Aug. 17 and the first back-to-back declines of more than 0.5% since before Election Day.
AET stock isn't a buy here, but only for logistical reasons. If you're already an Aetna shareholder, just hang on because it's about to get even better.
Rite Aid bulls hope it finds a buyer, while bears see it circling the drain. RAD stock might be fun to trade right now, but watch it closely.
From The Motley Fool